SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-036250
Filing Date
2021-03-15
Accepted
2021-03-15 16:13:13
Documents
2
Period of Report
2021-03-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219787d1_8k.htm 8-K 24864
2 EXHIBIT 16.1 tm219787d1_ex16-1.htm EX-16.1 2626
  Complete submission text file 0001104659-21-036250.txt   28617
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 21741630
SIC: 2834 Pharmaceutical Preparations